Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 28

1.

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.

Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, Fan J.

Clin Cancer Res. 2009 Sep 1;15(17):5518-27. doi: 10.1158/1078-0432.CCR-09-0151. Epub 2009 Aug 25.

2.

Bone morphogenetic protein-4 induced by NDRG2 expression inhibits MMP-9 activity in breast cancer cells.

Shon SK, Kim A, Kim JY, Kim KI, Yang Y, Lim JS.

Biochem Biophys Res Commun. 2009 Jul 24;385(2):198-203. doi: 10.1016/j.bbrc.2009.05.038. Epub 2009 May 19.

PMID:
19450561
3.

The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy.

Sagiv E, Arber N.

Expert Rev Gastroenterol Hepatol. 2008 Feb;2(1):125-33. doi: 10.1586/17474124.2.1.125. Review.

PMID:
19072375
4.

Immunohistochemical detection of Ndrg2 in the mouse nervous system.

Shen L, Zhao ZY, Wang YZ, Ji SP, Liu XP, Liu XW, Che HL, Lin W, Li X, Zhang J, Yao LB.

Neuroreport. 2008 Jun 11;19(9):927-31. doi: 10.1097/WNR.0b013e32830163d0.

PMID:
18520995
5.

Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.

Lee DC, Kang YK, Kim WH, Jang YJ, Kim DJ, Park IY, Sohn BH, Sohn HA, Lee HG, Lim JS, Kim JW, Song EY, Kim DM, Lee MN, Oh GT, Kim SJ, Park KC, Yoo HS, Choi JY, Yeom YI.

Cancer Res. 2008 Jun 1;68(11):4210-20. doi: 10.1158/0008-5472.CAN-07-5040.

6.

Gene expression-based recurrence prediction of hepatitis B virus-related human hepatocellular carcinoma.

Woo HG, Park ES, Cheon JH, Kim JH, Lee JS, Park BJ, Kim W, Park SC, Chung YJ, Kim BG, Yoon JH, Lee HS, Kim CY, Yi NJ, Suh KS, Lee KU, Chu IS, Roskams T, Thorgeirsson SS, Kim YJ.

Clin Cancer Res. 2008 Apr 1;14(7):2056-64. doi: 10.1158/1078-0432.CCR-07-1473.

7.

NDRG2 is a new HIF-1 target gene necessary for hypoxia-induced apoptosis in A549 cells.

Wang L, Liu N, Yao L, Li F, Zhang J, Deng Y, Liu J, Ji S, Yang A, Han H, Zhang Y, Zhang J, Han W, Liu X.

Cell Physiol Biochem. 2008;21(1-3):239-50. doi: 10.1159/000113765. Epub 2008 Jan 16.

8.

Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines.

Liu N, Wang L, Liu X, Yang Q, Zhang J, Zhang W, Wu Y, Shen L, Zhang Y, Yang A, Han H, Zhang J, Yao L.

Biochem Biophys Res Commun. 2007 Jun 22;358(1):164-9. Epub 2007 Apr 20.

PMID:
17470364
9.

CD24 and human carcinoma: tumor biological aspects.

Lim SC.

Biomed Pharmacother. 2005 Oct;59 Suppl 2:S351-4. Review.

PMID:
16507407
10.

CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis.

Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, Uede T, Yagita H, Sleeman JP.

Cancer Res. 2005 Dec 1;65(23):10783-93.

11.

The role of CD24 in various human epithelial neoplasias.

Lim SC, Oh SH.

Pathol Res Pract. 2005;201(7):479-86.

PMID:
16164042
12.

Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.

Bachman KE, Park BH.

Curr Opin Oncol. 2005 Jan;17(1):49-54. Review.

PMID:
15608513
13.

NDRG2 expression and mutation in human liver and pancreatic cancers.

Hu XL, Liu XP, Lin SX, Deng YC, Liu N, Li X, Yao LB.

World J Gastroenterol. 2004 Dec 1;10(23):3518-21.

14.

[Induction of apoptosis of HepG2 cells by NDRG2].

Wu GQ, Liu XP, Wang LF, Zhang WH, Zhang J, Li KZ, Dou KF, Zhang XF, Yao LB.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2003 Jul;19(4):357-60. Chinese.

PMID:
15163384
15.

CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer.

Kristiansen G, Pilarsky C, Pervan J, Stürzebecher B, Stephan C, Jung K, Loening S, Rosenthal A, Dietel M.

Prostate. 2004 Feb 1;58(2):183-92.

PMID:
14716744
16.

CD24 expression is a new prognostic marker in breast cancer.

Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M.

Clin Cancer Res. 2003 Oct 15;9(13):4906-13.

17.

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients.

Kristiansen G, Schlüns K, Yongwei Y, Denkert C, Dietel M, Petersen I.

Br J Cancer. 2003 Jan 27;88(2):231-6.

18.

CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival.

Kristiansen G, Denkert C, Schlüns K, Dahl E, Pilarsky C, Hauptmann S.

Am J Pathol. 2002 Oct;161(4):1215-21.

19.

Characterization of rat NDRG2 (N-Myc downstream regulated gene 2), a novel early mineralocorticoid-specific induced gene.

Boulkroun S, Fay M, Zennaro MC, Escoubet B, Jaisser F, Blot-Chabaud M, Farman N, Courtois-Coutry N.

J Biol Chem. 2002 Aug 30;277(35):31506-15. Epub 2002 Jun 18.

20.

Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer.

Welsh JB, Zarrinkar PP, Sapinoso LM, Kern SG, Behling CA, Monk BJ, Lockhart DJ, Burger RA, Hampton GM.

Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1176-81.

Supplemental Content

Support Center